11 New 4-Star Stocks

Overview

• Each week, Morningstar screens US-listed stocks under their coverage to identify undervalued names.
• For the week ending Nov. 8, 11 stocks were identified as becoming undervalued, moving to a 4 or 5-star rating.
• Ratings:
  • 4 or 5 stars: Undervalued
  • 3 stars: Fairly valued
  • 1 or 2 stars: Overvalued

Market Overview

• The Morningstar US Market Index rose 4.94% over the past week.
• US stock market is significantly overvalued, 11% premium to fair value estimate.

Stock Valuation Statistics

• 31% of US-listed stocks are undervalued.
• 40% are fairly valued.
• 29% are overvalued.
• 11 stocks are newly undervalued.
• 41 stocks are newly overvalued.
• 6 moved from 4-star to 5-star.
• 8 moved from 5-star to 4-star.
• 19 are no longer undervalued.

Factors Influencing Stock Ratings

• Morningstar assigns each stock a fair value estimate and an Uncertainty Rating.
• Fair Value Estimate: An intrinsic measure of a stock's worth.
• Uncertainty Rating: Captures range of potential outcomes for that estimate; higher rating indicates larger range of fair prices.

Newly Undervalued 4-Star Stocks

1. AstraZeneca

• Morningstar Rating: 4 stars
• One-Week Return: -9.70%
• 17% below fair value estimate ($78/share)
• Uncertainty Rating: Medium
• Wide moat

2. TotalEnergies

• Morningstar Rating: 4 stars
• One-Week Return: -1.98%
• 18% discount to fair value estimate ($75/share)
• Uncertainty Rating: High
• No moat

3. American Tower

• Morningstar Rating: 4 stars
• One-Week Return: -4.48%
• 12% below fair value estimate ($230/share)
• Uncertainty Rating: Medium
• Narrow moat

4. Banco Bradesco

• Morningstar Rating: 4 stars
• One-Week Return: -2.36%
• 19% discount to fair value estimate ($2.90/share)
• Uncertainty Rating: High
• No moat

5. Teva Pharmaceutical Industries

• Morningstar Rating: 4 stars
• One-Week Return: -7.26%
• 19% discount to new fair value estimate ($21/share)
• Uncertainty Rating: High
• No moat

6. Conagra Brands

• Morningstar Rating: 4 stars
• One-Week Return: -1.83%
• 14% discount to fair value estimate ($33/share)
• Uncertainty Rating: Medium
• No moat

7. Exact Sciences

• Morningstar Rating: 4 stars
• One-Week Return: -26.25%
• 24% discount to new fair value estimate ($68/share)
• Uncertainty Rating: Very High
• No moat

8. Teleflex

• Morningstar Rating: 4 stars
• One-Week Return: -7.41%
• 13% discount to fair value estimate ($225/share)
• Uncertainty Rating: Medium
• No moat

9. Sunrun

• Morningstar Rating: 4 stars
• One-Week Return: -30.69%
• 32% discount to fair value estimate ($15/share)
• Uncertainty Rating: Very High
• No moat

10. Marqeta

• Morningstar Rating: 4 stars
• One-Week Return: -36.07%
• 38% discount to new fair value estimate ($6/share)
• Uncertainty Rating: Very High
• No moat

Notes

• The article was generated with automation and reviewed by Morningstar editors.
• Authors do not own shares in the securities mentioned.
• Further details and editorial policies can be accessed through provided links.